Frontlight ResearchEarly access
Spinal muscular atrophy trials in Brazil
1 of 3 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleA Long-term Safety Study in Brazilian Patients With a Diagnosis of Spinal Muscular Atrophy Treated With Zolgensma
- Where
- Curitiba, São Paulo
- Age
- 0 years to 100 years
- People
- 50
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06019637